Benchmark analyst Robert Wasserman initiated coverage of Xoma (XOMA) with a Buy rating and $35 price target Xoma has expanded its royalty aggregate business through acquisitions and internal growth over the past several years, notes the analyst, who expects the R&D pipeline and recently completed commercial asset acquisitions to continue to drive double digit revenue growth over the next several years.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XOMA:
- Xoma completes sale of Kinnate Pipeline assets for up to $270M
- Strategic Growth Potential: Xoma’s Diversified Royalty Portfolio and Promising Phase 3 Asset
- XOMA Royalty Reports Strong 2024 Financial Growth
- Xoma’s Strong Financial Position and Strategic Growth Drive Buy Rating
- Xoma reports Q4 net loss $4M vs net loss $20.1M last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue